Abstract
Pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis are major global health challenges. Recent advances in drug delivery systems have significantly improved therapeutic outcomes by enhancing the bioavailability and targeting efficiency of pulmonary drugs. This article reviews innovative approaches in pulmonary drug delivery, including inhalation technologies, nanocarrier systems, and controlled-release formulations. The discussion also addresses current challenges and the future potential of these advanced systems in clinical settings.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.